We’re seeking proposals to ensure the nation is prepared for the next influenza pandemic. These partnerships will support US FDA-licensed manufacturing of influenza antigens & adjuvants and ensure vaccine capacity is available when needed. Proposals due 10/30/2026: ow.ly/NoNX50ZAZsv